BIO-key Expects 50% Increase in First Half Revenues, Driving Profitability in the Period
Rhea-AI Summary
BIO-key (Nasdaq: BKYI) expects 1H 2026 revenue of approximately $5.0M, up ~50% from $3.3M in 1H 2025, driven by software license momentum and stronger hardware sales.
The company expects positive net income in 1H 2026 versus a $1.9M loss in 1H 2025, a stable cash balance near $2.7M, and specific wins including a $1.04M one-year software renewal and over $1M in hardware contracts.
Positive
- Revenue +50% to ~$5.0M in 1H 2026
- Positive net income expected in 1H 2026 vs $1.9M loss
- $1.04M one-year software license renewal secured
- Over $1M in Pocket 10 and Mobile POS Pro contracts
Negative
- Cash position remains modest at $2.7M at 1H close
- Quarterly scale still small: Q1 $2.2M and Q2 $2.8M revenues
News Market Reaction – BKYI
In the Apr 16 session, BKYI gained 6.33%, reflecting a notable positive market reaction. Argus tracked a peak move of +10.9% during that session. Argus tracked a trough of -9.4% from its starting point during tracking. Our momentum scanner triggered 7 alerts that day, indicating moderate trading interest and price volatility. Trading volume was very high at 4.0x the daily average, suggesting strong buying interest.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 31 | 2025 results & outlook | Positive | -11.3% | Reported 2025 results, stronger cash, and expectation of stronger 2026 growth. |
| Mar 25 | Investor call notice | Neutral | +6.3% | Announced date and details for the 2025 year-end investor conference call. |
| Mar 12 | Public sector partnership | Positive | +4.3% | Partnered with TD SYNNEX Public Sector to sell IAM and biometric solutions to agencies. |
| Mar 05 | Defense sales milestone | Positive | +2.9% | Surpassed $2M in military/defense orders including a new $280,000 follow-on order. |
| Mar 03 | Bank license renewal | Positive | +5.1% | Secured expanded $1.04M license renewal with a foreign retail bank customer. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Most recent positive operational and contract updates have been followed by positive price reactions, with one notable divergence on a results-and-outlook release that coincided with an 11.35% decline.
Over the past six weeks, BIO-key has highlighted several milestones: a foreign retail bank’s expanded $1.04M license renewal serving over 30M clients, crossing $2M in military/defense sales including a $280,000 defense order, and a new public-sector partnership with TD SYNNEX Public Sector (DLT). On Mar 31, 2025 results and a substantially improved cash position were reported, yet the stock fell 11.35%. Today’s 1H’26 outlook builds directly on those contracts and preliminary Q1’26 growth commentary.
Key Terms
identity and access management (iam) technical
biometric authentication technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
HOLMDEL, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, previewed today its business outlook for the first half of 2026 (1H’26) ending June 30, 2026, supported by building software license momentum and strength in hardware revenues.
Expected 1H’26 Results:
- 1H’26 revenues expected to grow
50% to approximately$5M vs.$3.3M in 1H’25 - Positive net income expected in 1H’26 vs.
$1.9M net loss in 1H’25 - Cash position at the close of 1H’26 is expected to remain in line with
$2.7M at year-end 2025
Q1’26 & Q2’26 Expected Revenues:
- Q1’26 revenues expected to grow
37% to$2.2M vs.$1.6M in Q1’25 - Q2’26 revenues expected to grow
65% to$2.8M vs.$1.7M in Q2’25
BIO-key’s improved 1H’26 results reflect the benefit of a
BIO-key CEO, Mike DePasquale commented, “Our groundwork last year positioned BIO-key for solid top- and bottom-line improvements that are now coming into focus in the first half of 2026. Building on our growing base of annually recurring software licenses and services revenues, we see improving traction with larger contract opportunities, which we expect will benefit our results in the second half of 2026 and into 2027. These include an opportunity to deploy our biometric authentication technology with a foreign tax agency and potential deployment with a new foreign defense ministry, in addition to discussions with new enterprise customers, particularly in regulated industries where positive identity is essential.
“These developments underscore the demand we are creating directly and via partners, particularly in regions with favorable regulatory frameworks. Through disciplined management of margins and overhead, we expect our top-line growth to translate into meaningful improvement on the net income line and in our ability to fund further growth.”
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology and identity access management industries; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to migrate Swivel Secure customers to BIO-key and Portal Guard offerings; our ability to execute definitive agreements with Fiber Food Systems and/or its customers to utilize our access management solutions; our ability to integrate our solutions into any of Fiber Food System’s offerings; fluctuations in foreign currency exchange rates; the duration and extent of continued hostilities in Ukraine and its impact on our European customers; the impact of tariffs and other trade barriers which may make it more costly for us to import inventory from China and Hong Kong and certain product components from South Korea; delays in the development of products, the commercial, reputational and regulatory risks to our business that may arise as a consequence of non-compliance with Securities and Exchange Commission (“SEC”) and Nasdaq periodic reporting requirements; our temporary loss of the use of a Registration Statement on Form S-3 to register securities in the future; any disruption to our business that may occur on a longer-term basis should we be unable to continue to maintain effective internal controls over financial reporting, and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024 and other filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.
| Engage with BIO-key | |
| Facebook – Corporate: | https://www.facebook.com/BIOkeyInternational/ |
| LinkedIn – Corporate: | https://www.linkedin.com/company/bio-key-international |
| X – Corporate: | @BIOkeyIntl |
| X – Investors: StockTwits: | @BIO_keyIR BIO_keyIR |
Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com or 212-924-9800
